glp 1 study Cardiovascular and mortality outcomes with GLP-1 receptor agonists vs other glucose-lowering drugs in individuals with NAFLD and type 2 diabetes: a large population-based matched cohort | Diabetologia Another milestone in the evolution
Description
Mol Metab 6: 288294
Semaglutide is a GLP-1 receptor agonist, a peptide-based medication
These compounded medications have the same active ingredient as the name-brand drugs, but they might include other ingredients like vitamins, so they dont violate pharma patents
The question is always one of magnitude
